RHHBF:OTCMKTS
Roche Holding AG
458,47 $
arrow_downward
-0,33%(-1,53) 1D
15 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHBF...
Open
441,30 $
High
458,47 $
Low
441,30 $
Mkt. cap
369,78 մլրդ
Avg. vol.
63,00
Volume
8,00
P/E ratio
199,18
52-wk high
514,08 $
52-wk low
301,27 $
EPS
2,30 $
Beta
0,45
Shares outstanding
106,69 մլն
No. of employees
113 հզր
Open
441,30 $
High
458,47 $
Low
441,30 $
Mkt. cap
369,78 մլրդ
Avg. vol.
63,00
Volume
8,00
P/E ratio
199,18
52-wk high
514,08 $
52-wk low
301,27 $
EPS
2,30 $
Beta
0,45
Shares outstanding
106,69 մլն
No. of employees
113 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
1 ժամ առաջ
Roche secures ALK7 license. Roche Holding stock costs EUR 407.60
Yahoo Finance
·
5 ժամ առաջ
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
Reuters
·
2 օր առաջ
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
2 օր առաջ
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG
CEOThomas Schinecker
Employees113 հզր
Founded01 հոկ, 1896 թ.
HeadquartersԲասել, Basel City, Շվեյցարիա
Sector-
Websiteroche.com